Article · 19 Feb 2026
Conference abstractPublished 21 Oct 2021
Update on Management of Postoperative Atrial Fibrillation After Cardiac Surgery
Emeritus professor of cardiology, Alexandria University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Postoperative atrial fibrillation (POAF) after cardiac surgery remains the most prevalent arrhythmia in perioperative cardiac surgery, having great clinical impact. The purpose of this presentation is to show the causes, prevention and management of this subject according to recent guidelines. The primary objectives of POAF management are to maintain hemodynamic stability, control the symptoms, and prevent thromboembolism and recurrence. The antiarrhythmic strategy showed a tendency (P=0.08) to reduce the time to sinus rhythm reversion. There was also reduced length of hospital stay in the group receiving antiarrhythmic drugs (P=0.05). The control of ventricular response during AF can be performed with various drugs, including digitalis, beta-blockers, and calcium channel blockers. The option of electrical cardioversion for rhythm control should be used in the presence of hemodynamic instability, acute cardiac insufficiency, or myocardial ischemia. The beta-blocking action is particularly effective for heart rate control in the postoperative period. Anticoagulation Strategies for the Management POAF: With respect to prevention of thromboembolic phenomena, POAF is associated with a higher risk of stroke, ranging from 1.9% to 18.2%, that emphasizes the use of therapeutic anticoagulation. The American College of Chest Physicians (ACCP) recommends the use of anticoagulation particularly for high-risk patients, such as those with a history of stroke or transient ischemic. The merit of anticoagulation in postoperative patients after cardiac surgery should be carefully weighed against the increased risk of bleeding. This risk may even exceed the benefits in reducing stroke in some patients. Biography and Expertise - The previous head of the cardiology department, Faculty of Medicine, Alexandria University, Egypt - Published 55 papers listed in Google Scholar, H index 3 , Citations 29, Researchgate score 20.38 - Reviewer in National council for the promotion of professors in cardiology and critical care, reviewer of some journals, grader of abstracts of the European Society of Cardiology conference, and EHRA European Heart Rhythm Association conference. - Worked in ablation and device implantation in Alexandria Faculty of Medicine - Chairperson or speaker in Many conferences inside and outside Egypt
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cardiovascular Diseases & Diagnosis.
Brief report · 29 Dec 2025
AI Transforms Cardiology: Diagnosis to Personalized Care
Brief report · 29 Dec 2025
Minimally Invasive Cardiac Surgery: Advancements and Outcomes
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCardiovascular Diseases & Diagnosis
- SubjectCardiology
- BylineArticles whose byline prints “Samir Rafla”
